MIGS: Micro-Invasive Glaucoma Surgery – Challenges & Opportunities
Bringing together a diverse range of experts for the panel discussion on MIGS at the 2nd Annual Ophthalmology Innovation Summit, co-moderators Tom Samuelson of Minnesota Eye Consultants and Kerry Solomon of Carolina Eyecare Research Institute, lead panelists Tom Burns of Glaukos Corporation, Ron Bache of AqueSys, Inc, David Van Meter of Ivantis, Brian Walsh of Transcend Medical, Richard Lewis of Surgical Eye Specialists and Ike Ahmed of the University of Toronto through a conversation surrounding the present challenges and future opportunities emerging in the rapidly growing market surrounding MIGS.
Moderator:
Kerry Solomon, MD
Kerry D. Solomon, MD, is a cataract, LASIK and advanced vision correction specialist at Carolina Eyecare Physicians, Director of the Carolina Eyecare Research Institute, and Clinical Professor of Ophthalmology at the Medical University of South Carolina.
Panelists:
Thomas Burns
Mr. Burns has provided the leadership for Glaukos since its founding in 2001 to create the premier device franchise in glaucoma treatment– a business that was recently ranked #19 by the Wall Street Journal in a review of over 5000 venture-backed companies.
Ron Bache
Ron Bache is President and CEO of AqueSys, Inc. AqueSys is a venture capital backed medical device company focused on the development, and commercialization of innovative, safe, and effective implantable devices for the treatment of glaucoma.
David Van Meter
Dave joined Ivantis as President/CEO in 2008. Previously, starting in 2001, Dave worked at Abbott’s Vascular Division, where he was an early leader in the creation and growth of a business that grew from $60 to $400 MM from 2001 until 2006.
Richard Lewis, MD
Richard A. Lewis, M.D. is the former director of glaucoma at the University of California, Davis. In addition to his busy clinical practice located in Sacramento, California, Dr. Lewis is actively involved in clinical research in national and international trials in anterior segment disease and glaucoma therapy.
Ike Ahmed, MD
Dr. Ahmed is currently Assistant Professor at the University of Toronto and Professor at the University of Utah. He is the Research Director at the Kensington Eye Institute and the Director of the Glaucoma and Advanced Anterior Segment Surgery (GAASS) fellowship, both at the University of Toronto.